Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- Check3 days agoChange DetectedRevision label changed from v3.3.3 to v3.3.4. This appears to be a minor metadata update with no changes to the study content, eligibility criteria, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study’s locations were updated: new site regions across the United States and internationally were added, and several prior location groups were removed, reflecting an updated site network (revision: v3.3.3).SummaryDifference2%

- Check53 days agoChange DetectedRevision history updated to include Revision: v3.3.2 and remove Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.3.1 is now displayed, replacing the previous v3.2.0.SummaryDifference0.2%

- Check67 days agoChange DetectedThe funding-status warning banner about government funding lapses was removed. The page continues to present the study details and locations.SummaryDifference0.2%

- Check81 days agoChange DetectedCore study details appear unchanged. The visible updates seem to be routine metadata like the study location list and the update timestamp.SummaryDifference0.2%

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.